View of Atezolizumab for non-small cell lung cancer: Is it cost-effective? A comprehensive systematic review and meta-analysis

Return to Article Details Atezolizumab for non-small cell lung cancer: Is it cost-effective? A comprehensive systematic review and meta-analysis Download Download PDF